Brief: Tryptamine Therapeutics Seeks Trading Halt
Aug 7 (Reuters) - Tryptamine Therapeutics Ltd TYP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CO’S TRP-8802
(ORAL
PSILOCYBIN) STUDY
Further company coverage: TYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt